http://ift.tt/eA8V8J
SHANGHAI, May 30, 2017 /PRNewswire/ — InventisBio, a fast-growing biotech company dedicated to the discovery and development of novel medicines, today announced that it had successfully raised USD19 million in a Series B financing. The investment was led by OrbiMed Asia Partners and…
May 31, 2017 at 04:31AM
from
No comments:
Post a Comment